SBIR-STTR Award

Development of a Small GC-IMS to Rapidly Detect and Identify Target Compounds of Military and National Security Interest
Award last edited on: 11/27/2002

Sponsored Program
SBIR
Awarding Agency
DOD : DARPA
Total Award Amount
$848,513
Award Phase
2
Solicitation Topic Code
SB961-036
Principal Investigator
Glenn E Spangler

Company Information

Technispan LLC

1209 Malbay Drive
Lutherville, MD 21093
   (410) 296-8361
   tspan@verizon.net
   N/A
Location: Single
Congr. District: 02
County: Baltimore

Phase I

Contract Number: ----------
Start Date: ----    Completed: ----
Phase I year
1996
Phase I Amount
$98,522
The proliferation of weapons of mass destruction (WMD) continues to constitute a serious threat to the security of the United States. Early detection and warning of the use of the WMD on the battlefield is a top priority of the Department of Defense. Likewise, the identification and characterization of WMD facilities and capabilities worldwide comprise critical elements of United States endeavors to counter their proliferation. These national security thrusts, both battlefield defense and intelligence gathering, require the detection of chemical and biological agents, as well as precursors and by-products in their production. Also, other health related issues arising from the Persian Gulf War underscore the need to detect and identify other hazardous and toxic materials in the theater. Ion Mobility Spectrometry (IMS) is proving to be a very effective technology to detect targeted compounds in the battlefield and other sensitive scenarios. The Chemical Agent Monitor (CAM) has already been deployed as a handheld IMS detector. The combination of gas chromatography (GC) with IMS, however, should provide an improved detection capability over CAM which can be plagued with disabling interferences in certain scenarios. This proposal addresses the design of a miniaturized GC-IMS which promises to significantly reduce the size, weight and power of the device without compromising performance.

Phase II

Contract Number: ----------
Start Date: ----    Completed: ----
Phase II year
1997
Phase II Amount
$749,991
The proliferation of weapons of mass destruction (WMD) continues to constitute a serious threat to the security of the United States. Early detection and warning of the use of WMD on the battlefield is a top priority of the Department of Defense. Likewise, the identification and characterization of WMD facilities and capabilities worldwide comprise critical elements of the United states endeavors to counter their proliferation. These national security thrusts, both battlefield defense and intelligence gathering, require the detection of chemical and biological agents, as well as precursors and by-products in their production. Also, other health related issues arising from the Persian Gulf War Underscore the need to detect and identify other hazardous and toxic materials in the theatre. Technispan LLC, in alliance with Texas Christian University and SRI, International, is developing ion mobility spectrometry (IMS) in combination with gas chromatography (GC-IMS) to address this application. GC-IMS should provide an improved detection capability over current stand alone devices that are susceptible to disabling interferences in certain scenarios. During Phase I, the theoretical issues associated with reducing the size, weight and power of a GC -IMS, without compromising performance, were investigated. During Phase II, a miniaturized GC-IMS will be designed, fabricated and tested following the recommendations of Phase I.